{
  "run_id": "RUN_20260204_132700_1fed028ce5fb",
  "timestamp": "2026-02-04T16:16:34.897906",
  "document": "05_01195_TRPC channels contribute to endothelial dysfunction in pulmonary arterial hypertension.pdf",
  "document_path": "/Users/frederictetard/Projects/ese/gold_data/PAPERS/05_01195_TRPC channels contribute to endothelial dysfunction in pulmonary arterial hypertension.pdf",
  "pipeline_version": "0.8",
  "total_candidates": 29,
  "total_validated": 29,
  "total_rejected": 0,
  "genes": [
    {
      "matched_text": "TRPC3",
      "hgnc_symbol": "TRPC3",
      "full_name": "transient receptor potential cation channel subfamily C member 3",
      "confidence": 0.85,
      "is_alias": false,
      "locus_type": "gene with protein product",
      "chromosome": null,
      "codes": {
        "hgnc_id": "12335",
        "entrez": "7222",
        "ensembl": "ENSG00000138741",
        "uniprot": "Q13507",
        "omim": "602345"
      },
      "all_identifiers": [
        {
          "system": "HGNC",
          "code": "12335",
          "display": null
        },
        {
          "system": "ENTREZ",
          "code": "7222",
          "display": null
        },
        {
          "system": "ENSEMBL",
          "code": "ENSG00000138741",
          "display": null
        },
        {
          "system": "OMIM",
          "code": "602345",
          "display": null
        },
        {
          "system": "UNIPROT",
          "code": "Q13507",
          "display": null
        }
      ],
      "associated_diseases": [
        {
          "orphacode": "458798",
          "disease_name": "Spinocerebellar ataxia type 41",
          "association_type": "Disease-causing germline mutation(s) in"
        }
      ],
      "context": "tial in these processes. Among the various channels involved in Ca** homeostasis, transient receptor potential canonical channels (TRPC1 to 7) are known to be essential for endothelial cells of various origins, but their role in PAH remains unknown.\n\nResults-We found that four TRPC channels (TRPC1, TRPC3, TRPC4, and TRPC6) were expressed in human pulmonary endothelial cells (PECs) from control and PAH patients. By knocking down each of these channels in hPECs isolated from PAH patients (PAH-hPECs), we found that TRPC1 and TRPC4 are involved in store-operated Ca** entry (SOCE). We showed that TRPC1",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_08_orphadata_genes.json",
      "validation_flags": [
        "auto_validated_lexicon",
        "deduplicated"
      ]
    },
    {
      "matched_text": "TRPC6",
      "hgnc_symbol": "TRPC6",
      "full_name": "transient receptor potential cation channel subfamily C member 6",
      "confidence": 0.85,
      "is_alias": false,
      "locus_type": "gene with protein product",
      "chromosome": null,
      "codes": {
        "hgnc_id": "12338",
        "entrez": "7225",
        "ensembl": "ENSG00000137672",
        "uniprot": "Q9Y210",
        "omim": "603652"
      },
      "all_identifiers": [
        {
          "system": "HGNC",
          "code": "12338",
          "display": null
        },
        {
          "system": "ENTREZ",
          "code": "7225",
          "display": null
        },
        {
          "system": "ENSEMBL",
          "code": "ENSG00000137672",
          "display": null
        },
        {
          "system": "OMIM",
          "code": "603652",
          "display": null
        },
        {
          "system": "UNIPROT",
          "code": "Q9Y210",
          "display": null
        }
      ],
      "associated_diseases": [
        {
          "orphacode": "656",
          "disease_name": "Hereditary steroid-resistant nephrotic syndrome",
          "association_type": "Disease-causing germline mutation(s) (gain of function) in"
        }
      ],
      "context": "esses. Among the various channels involved in Ca** homeostasis, transient receptor potential canonical channels (TRPC1 to 7) are known to be essential for endothelial cells of various origins, but their role in PAH remains unknown.\n\nResults-We found that four TRPC channels (TRPC1, TRPC3, TRPC4, and TRPC6) were expressed in human pulmonary endothelial cells (PECs) from control and PAH patients. By knocking down each of these channels in hPECs isolated from PAH patients (PAH-hPECs), we found that TRPC1 and TRPC4 are involved in store-operated Ca** entry (SOCE). We showed that TRPC1 and TRPC3 are esse",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_08_orphadata_genes.json",
      "validation_flags": [
        "auto_validated_lexicon",
        "deduplicated"
      ]
    },
    {
      "matched_text": "vWF",
      "hgnc_symbol": "VWF",
      "full_name": "von Willebrand factor",
      "confidence": 0.85,
      "is_alias": false,
      "locus_type": "gene with protein product",
      "chromosome": null,
      "codes": {
        "hgnc_id": "12726",
        "entrez": "7450",
        "ensembl": "ENSG00000110799",
        "uniprot": "P04275",
        "omim": "613160"
      },
      "all_identifiers": [
        {
          "system": "HGNC",
          "code": "12726",
          "display": null
        },
        {
          "system": "ENTREZ",
          "code": "7450",
          "display": null
        },
        {
          "system": "ENSEMBL",
          "code": "ENSG00000110799",
          "display": null
        },
        {
          "system": "OMIM",
          "code": "613160",
          "display": null
        },
        {
          "system": "UNIPROT",
          "code": "P04275",
          "display": null
        }
      ],
      "associated_diseases": [
        {
          "orphacode": "166078",
          "disease_name": "Von Willebrand disease type 1",
          "association_type": "Disease-causing germline mutation(s) in"
        },
        {
          "orphacode": "166084",
          "disease_name": "Von Willebrand disease type 2A",
          "association_type": "Disease-causing germline mutation(s) in"
        },
        {
          "orphacode": "166090",
          "disease_name": "Von Willebrand disease type 2M",
          "association_type": "Disease-causing germline mutation(s) in"
        },
        {
          "orphacode": "166087",
          "disease_name": "Von Willebrand disease type 2B",
          "association_type": "Disease-causing germline mutation(s) in"
        },
        {
          "orphacode": "166093",
          "disease_name": "Von Willebrand disease type 2N",
          "association_type": "Disease-causing germline mutation(s) in"
        },
        {
          "orphacode": "166096",
          "disease_name": "Von Willebrand disease type 3",
          "association_type": "Disease-causing germline mutation(s) in"
        }
      ],
      "context": "University, Créteil, France 3Inserm, UMR_S 1180, Signalisation et Physiopathologie Cardiovasculaire, Université Paris-Saclay, Orsay, France\n\nIntroduction\n\nare expressed in the PA, and more particularly in hPECs in control and PAH patients as indicated by the co-staining with von Willebrand factor (vWF) (Fig. 1A). To decipher the role of each expressed TRPC channel, we performed in vitro experiments using control-hPECs.\n\nEndothelial cell dysfunction is a key contributor to the pathogenesis of pulmonary arterial (PA) hypertension (PAH), a rare and life-threatening pulmonary vascular disease define",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_08_orphadata_genes.json",
      "validation_flags": [
        "auto_validated_lexicon",
        "deduplicated"
      ]
    },
    {
      "matched_text": "PAH",
      "hgnc_symbol": "PAH",
      "full_name": "phenylalanine hydroxylase",
      "confidence": 0.85,
      "is_alias": false,
      "locus_type": "gene with protein product",
      "chromosome": null,
      "codes": {
        "hgnc_id": "8582",
        "entrez": "5053",
        "ensembl": "ENSG00000171759",
        "uniprot": "P00439",
        "omim": "612349"
      },
      "all_identifiers": [
        {
          "system": "HGNC",
          "code": "8582",
          "display": null
        },
        {
          "system": "ENTREZ",
          "code": "5053",
          "display": null
        },
        {
          "system": "ENSEMBL",
          "code": "ENSG00000171759",
          "display": null
        },
        {
          "system": "OMIM",
          "code": "612349",
          "display": null
        },
        {
          "system": "UNIPROT",
          "code": "P00439",
          "display": null
        }
      ],
      "associated_diseases": [
        {
          "orphacode": "2209",
          "disease_name": "Maternal phenylketonuria syndrome",
          "association_type": "Disease-causing germline mutation(s) in"
        },
        {
          "orphacode": "293284",
          "disease_name": "Tetrahydrobiopterin-responsive phenylketonuria",
          "association_type": "Disease-causing germline mutation(s) in"
        },
        {
          "orphacode": "708895",
          "disease_name": "Tetrahydrobiopterin-unresponsive phenylketonuria",
          "association_type": "Disease-causing germline mutation(s) in"
        }
      ],
      "context": "TRPC3 nor siTRPC6 altered histamine-induced Ca’* signaling in control-hPECs (Fig. 1G).\n\nMoreover, we found that TRPC3 and TRPC4 are involved in control-hPECs proliferation (Fig. 1H) and that TRPC1 and TRPC6 are involved in migration (Fig. 11).\n\nThe expression of TRPC1, TRPC4, and TRPC6 increased in PAH-hPECs compared to control patients\n\ncounteract PAH development [10, 12-14].\n\nWe investigated the expression, localization, and functional role of TRPC channels in hPECs isolated from control and PAH patients, focusing on their involvement in intracellular Ca”* signaling and their contribution to pr",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_08_orphadata_genes.json",
      "validation_flags": [
        "auto_validated_lexicon",
        "deduplicated"
      ]
    },
    {
      "matched_text": "Tg",
      "hgnc_symbol": "TG",
      "full_name": "thyroglobulin",
      "confidence": 0.85,
      "is_alias": false,
      "locus_type": "gene with protein product",
      "chromosome": null,
      "codes": {
        "hgnc_id": "11764",
        "entrez": "7038",
        "ensembl": "ENSG00000042832",
        "uniprot": "P01266",
        "omim": "188450"
      },
      "all_identifiers": [
        {
          "system": "HGNC",
          "code": "11764",
          "display": null
        },
        {
          "system": "ENTREZ",
          "code": "7038",
          "display": null
        },
        {
          "system": "ENSEMBL",
          "code": "ENSG00000042832",
          "display": null
        },
        {
          "system": "OMIM",
          "code": "188450",
          "display": null
        },
        {
          "system": "UNIPROT",
          "code": "P01266",
          "display": null
        }
      ],
      "associated_diseases": [
        {
          "orphacode": "95716",
          "disease_name": "Familial thyroid dyshormonogenesis",
          "association_type": "Disease-causing germline mutation(s) in"
        }
      ],
      "context": "control-hPECs, while TRPC3 protein expression was unchanged (Fig. 2B).\n\nResults\n\nTRPC channels are expressed in control-hPECs and participate in cell function\n\nImmunofluorescent staining in human lung sections demonstrated that TRPC1, TRPC3, TRPC4, and TRPC6\n\nFura2/AM Ca** imaging experiments with Tg (Fig. 3A) revealed that ER Ca** content (Fig. 3B) and SOCE\n\nControl-hPECs\n\nControl-hPASMCs\n\n+ ee iS ‘La\n\nFig. 1 (See legend on next page.)\n\nNormalized\n\n(See figure on previous page.)\n\nFig. 1 TRPC channels expression in control-hPECs. A Expression and localization of TRPC1, TRPC3, TRPC4, and TRPC6 b",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_08_orphadata_genes.json",
      "validation_flags": [
        "auto_validated_lexicon",
        "deduplicated"
      ]
    },
    {
      "matched_text": "PPARGC1A",
      "hgnc_symbol": "PPARGC1A",
      "full_name": "PPARG coactivator 1 alpha",
      "confidence": 0.85,
      "is_alias": false,
      "locus_type": "gene with protein product",
      "chromosome": null,
      "codes": {
        "hgnc_id": "9237",
        "entrez": "10891",
        "ensembl": "ENSG00000109819",
        "uniprot": "Q9UBK2",
        "omim": "604517"
      },
      "all_identifiers": [
        {
          "system": "HGNC",
          "code": "9237",
          "display": null
        },
        {
          "system": "ENTREZ",
          "code": "10891",
          "display": null
        },
        {
          "system": "ENSEMBL",
          "code": "ENSG00000109819",
          "display": null
        },
        {
          "system": "OMIM",
          "code": "604517",
          "display": null
        },
        {
          "system": "UNIPROT",
          "code": "Q9UBK2",
          "display": null
        }
      ],
      "associated_diseases": [
        {
          "orphacode": "803",
          "disease_name": "Amyotrophic lateral sclerosis",
          "association_type": "Modifying germline mutation in"
        }
      ],
      "context": "or each condition). ns=non significant; * P< 0.05, **P<0.01\n\n(Fig. 3C) were unchanged in PAH-hPECs compared to control-hPECs, while histamine-induced Ca’* signaling was reduced in PAH-hPECs compared to control-hPECs (Fig. 3D-E).\n\nPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-Alpha (PPARGC1A), Endothelin receptor type A (EDNRA) and Angiotensin II Receptor Type 1 (AGTR1) (Fig. 6A). Moreover, no significant change was observed in the expression of the other 80 endothelial markers (Table 3). These results suggest that TRPC1 partly contributes to endothelial dysfunction in PAH disease. We",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_08_orphadata_genes.json",
      "validation_flags": [
        "auto_validated_lexicon",
        "deduplicated"
      ]
    },
    {
      "matched_text": "EDNRA",
      "hgnc_symbol": "EDNRA",
      "full_name": "endothelin receptor type A",
      "confidence": 0.85,
      "is_alias": false,
      "locus_type": "gene with protein product",
      "chromosome": null,
      "codes": {
        "hgnc_id": "3179",
        "entrez": "1909",
        "ensembl": "ENSG00000151617",
        "uniprot": "P25101",
        "omim": "131243"
      },
      "all_identifiers": [
        {
          "system": "HGNC",
          "code": "3179",
          "display": null
        },
        {
          "system": "ENTREZ",
          "code": "1909",
          "display": null
        },
        {
          "system": "ENSEMBL",
          "code": "ENSG00000151617",
          "display": null
        },
        {
          "system": "OMIM",
          "code": "131243",
          "display": null
        },
        {
          "system": "UNIPROT",
          "code": "P25101",
          "display": null
        }
      ],
      "associated_diseases": [
        {
          "orphacode": "586",
          "disease_name": "Cystic fibrosis",
          "association_type": "Modifying germline mutation in"
        },
        {
          "orphacode": "443995",
          "disease_name": "Mandibulofacial dysostosis with alopecia",
          "association_type": "Disease-causing germline mutation(s) (gain of function) in"
        }
      ],
      "context": "* P< 0.05, **P<0.01\n\n(Fig. 3C) were unchanged in PAH-hPECs compared to control-hPECs, while histamine-induced Ca’* signaling was reduced in PAH-hPECs compared to control-hPECs (Fig. 3D-E).\n\nPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-Alpha (PPARGC1A), Endothelin receptor type A (EDNRA) and Angiotensin II Receptor Type 1 (AGTR1) (Fig. 6A). Moreover, no significant change was observed in the expression of the other 80 endothelial markers (Table 3). These results suggest that TRPC1 partly contributes to endothelial dysfunction in PAH disease. We also found that TRPC3 knockdown incr",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_08_orphadata_genes.json",
      "validation_flags": [
        "auto_validated_lexicon",
        "deduplicated"
      ]
    },
    {
      "matched_text": "AGTR1",
      "hgnc_symbol": "AGTR1",
      "full_name": "angiotensin II receptor type 1",
      "confidence": 0.85,
      "is_alias": false,
      "locus_type": "gene with protein product",
      "chromosome": null,
      "codes": {
        "hgnc_id": "336",
        "entrez": "185",
        "ensembl": "ENSG00000144891",
        "uniprot": "P30556",
        "omim": "106165"
      },
      "all_identifiers": [
        {
          "system": "HGNC",
          "code": "336",
          "display": null
        },
        {
          "system": "ENTREZ",
          "code": "185",
          "display": null
        },
        {
          "system": "ENSEMBL",
          "code": "ENSG00000144891",
          "display": null
        },
        {
          "system": "OMIM",
          "code": "106165",
          "display": null
        },
        {
          "system": "UNIPROT",
          "code": "P30556",
          "display": null
        }
      ],
      "associated_diseases": [
        {
          "orphacode": "97369",
          "disease_name": "Renal tubular dysgenesis of genetic origin",
          "association_type": "Disease-causing germline mutation(s) in"
        }
      ],
      "context": "ged in PAH-hPECs compared to control-hPECs, while histamine-induced Ca’* signaling was reduced in PAH-hPECs compared to control-hPECs (Fig. 3D-E).\n\nPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-Alpha (PPARGC1A), Endothelin receptor type A (EDNRA) and Angiotensin II Receptor Type 1 (AGTR1) (Fig. 6A). Moreover, no significant change was observed in the expression of the other 80 endothelial markers (Table 3). These results suggest that TRPC1 partly contributes to endothelial dysfunction in PAH disease. We also found that TRPC3 knockdown increased mRNA expression of TNF Receptor Super",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_08_orphadata_genes.json",
      "validation_flags": [
        "auto_validated_lexicon",
        "deduplicated"
      ]
    },
    {
      "matched_text": "CD40",
      "hgnc_symbol": "CD40",
      "full_name": "CD40 molecule",
      "confidence": 0.85,
      "is_alias": false,
      "locus_type": "gene with protein product",
      "chromosome": null,
      "codes": {
        "hgnc_id": "11919",
        "entrez": "958",
        "ensembl": "ENSG00000101017",
        "uniprot": "P25942",
        "omim": "109535"
      },
      "all_identifiers": [
        {
          "system": "HGNC",
          "code": "11919",
          "display": null
        },
        {
          "system": "ENTREZ",
          "code": "958",
          "display": null
        },
        {
          "system": "ENSEMBL",
          "code": "ENSG00000101017",
          "display": null
        },
        {
          "system": "OMIM",
          "code": "109535",
          "display": null
        },
        {
          "system": "UNIPROT",
          "code": "P25942",
          "display": null
        }
      ],
      "associated_diseases": [
        {
          "orphacode": "101090",
          "disease_name": "Hyper-IgM syndrome type 3",
          "association_type": "Disease-causing germline mutation(s) in"
        }
      ],
      "context": "over, no significant change was observed in the expression of the other 80 endothelial markers (Table 3). These results suggest that TRPC1 partly contributes to endothelial dysfunction in PAH disease. We also found that TRPC3 knockdown increased mRNA expression of TNF Receptor Superfamily Member 5 (CD40) (Fig. 6B) and that TRPC4 knockdown reduced the mRNA level of Histone Deacetylase 5 (HDAC5) (Fig. 6C) without significantly affecting the expression of other endothelial markers. TRPC6 knockdown did not induce a change in mRNA of these 90 endothelial markers (data not shown).\n\nTRPC knockdown reduce",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_08_orphadata_genes.json",
      "validation_flags": [
        "auto_validated_lexicon",
        "deduplicated"
      ]
    },
    {
      "matched_text": "CD40LG",
      "hgnc_symbol": "CD40LG",
      "full_name": "CD40 ligand",
      "confidence": 0.85,
      "is_alias": false,
      "locus_type": "gene with protein product",
      "chromosome": null,
      "codes": {
        "hgnc_id": "11935",
        "entrez": "959",
        "ensembl": "ENSG00000102245",
        "uniprot": "P29965",
        "omim": "300386"
      },
      "all_identifiers": [
        {
          "system": "HGNC",
          "code": "11935",
          "display": null
        },
        {
          "system": "ENTREZ",
          "code": "959",
          "display": null
        },
        {
          "system": "ENSEMBL",
          "code": "ENSG00000102245",
          "display": null
        },
        {
          "system": "OMIM",
          "code": "300386",
          "display": null
        },
        {
          "system": "UNIPROT",
          "code": "P29965",
          "display": null
        }
      ],
      "associated_diseases": [
        {
          "orphacode": "101088",
          "disease_name": "X-linked hyper-IgM syndrome",
          "association_type": "Disease-causing germline mutation(s) in"
        }
      ],
      "context": "several growth factors is a key feature of pulmonary endothelial dysfunction in PAH,\n\nTo better understand the role played by TRPC channels in PAH-hPECs, we quantified the expression of 90 endothelial markers by RT-qPCR assay. We found that TRPC1 knockdown increased mRNA expression of CD40 Ligand (CD40LG), Interleukin 1 Beta (IL-1B), Tumor Necrosis Factor (TNF), prostaglan-din F receptor (PTGFR), Angiopoietin 1 (ANGPT1), Leptin (LEP) Interferon Regulatory Factor 3 (IRF3),\n\nMagnitude XS\n\nPAH lungs\n\nB Control and PAH-hPECs\n\n100 kDa-43 kDa-\n\n*\n\n.\n\n100 kDa-\n\n43 kDa~\n\n100 kDa 110 kDa-43kDa-\n\n.\n\nPS\n\nee",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_08_orphadata_genes.json",
      "validation_flags": [
        "auto_validated_lexicon",
        "deduplicated"
      ]
    },
    {
      "matched_text": "ANGPT1",
      "hgnc_symbol": "ANGPT1",
      "full_name": "angiopoietin 1",
      "confidence": 0.85,
      "is_alias": false,
      "locus_type": "gene with protein product",
      "chromosome": null,
      "codes": {
        "hgnc_id": "484",
        "entrez": "284",
        "ensembl": "ENSG00000154188",
        "uniprot": "Q15389",
        "omim": "601667"
      },
      "all_identifiers": [
        {
          "system": "HGNC",
          "code": "484",
          "display": null
        },
        {
          "system": "ENTREZ",
          "code": "284",
          "display": null
        },
        {
          "system": "ENSEMBL",
          "code": "ENSG00000154188",
          "display": null
        },
        {
          "system": "OMIM",
          "code": "601667",
          "display": null
        },
        {
          "system": "UNIPROT",
          "code": "Q15389",
          "display": null
        }
      ],
      "associated_diseases": [
        {
          "orphacode": "599418",
          "disease_name": "Hereditary angioedema with normal C1Inh not related to F12 or PLG variant",
          "association_type": "Disease-causing germline mutation(s) in"
        }
      ],
      "context": "played by TRPC channels in PAH-hPECs, we quantified the expression of 90 endothelial markers by RT-qPCR assay. We found that TRPC1 knockdown increased mRNA expression of CD40 Ligand (CD40LG), Interleukin 1 Beta (IL-1B), Tumor Necrosis Factor (TNF), prostaglan-din F receptor (PTGFR), Angiopoietin 1 (ANGPT1), Leptin (LEP) Interferon Regulatory Factor 3 (IRF3),\n\nMagnitude XS\n\nPAH lungs\n\nB Control and PAH-hPECs\n\n100 kDa-43 kDa-\n\n*\n\n.\n\n100 kDa-\n\n43 kDa~\n\n100 kDa 110 kDa-43kDa-\n\n.\n\nPS\n\nee\n\nFig. 2 Comparison of TRPC localization and expression in control-hPECs and PAH-hPECs. A Expression and localization o",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_08_orphadata_genes.json",
      "validation_flags": [
        "auto_validated_lexicon",
        "deduplicated"
      ]
    },
    {
      "matched_text": "LEP",
      "hgnc_symbol": "LEP",
      "full_name": "leptin",
      "confidence": 0.85,
      "is_alias": false,
      "locus_type": "gene with protein product",
      "chromosome": null,
      "codes": {
        "hgnc_id": "6553",
        "entrez": "3952",
        "ensembl": "ENSG00000174697",
        "uniprot": "P41159",
        "omim": "164160"
      },
      "all_identifiers": [
        {
          "system": "HGNC",
          "code": "6553",
          "display": null
        },
        {
          "system": "ENTREZ",
          "code": "3952",
          "display": null
        },
        {
          "system": "ENSEMBL",
          "code": "ENSG00000174697",
          "display": null
        },
        {
          "system": "OMIM",
          "code": "164160",
          "display": null
        },
        {
          "system": "UNIPROT",
          "code": "P41159",
          "display": null
        }
      ],
      "associated_diseases": [
        {
          "orphacode": "66628",
          "disease_name": "Obesity due to congenital leptin deficiency",
          "association_type": "Disease-causing germline mutation(s) in"
        }
      ],
      "context": "annels in PAH-hPECs, we quantified the expression of 90 endothelial markers by RT-qPCR assay. We found that TRPC1 knockdown increased mRNA expression of CD40 Ligand (CD40LG), Interleukin 1 Beta (IL-1B), Tumor Necrosis Factor (TNF), prostaglan-din F receptor (PTGFR), Angiopoietin 1 (ANGPT1), Leptin (LEP) Interferon Regulatory Factor 3 (IRF3),\n\nMagnitude XS\n\nPAH lungs\n\nB Control and PAH-hPECs\n\n100 kDa-43 kDa-\n\n*\n\n.\n\n100 kDa-\n\n43 kDa~\n\n100 kDa 110 kDa-43kDa-\n\n.\n\nPS\n\nee\n\nFig. 2 Comparison of TRPC localization and expression in control-hPECs and PAH-hPECs. A Expression and localization of TRPC1, TRPC3",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_08_orphadata_genes.json",
      "validation_flags": [
        "auto_validated_lexicon",
        "deduplicated"
      ]
    },
    {
      "matched_text": "BMPR2",
      "hgnc_symbol": "BMPR2",
      "full_name": "bone morphogenetic protein receptor type 2",
      "confidence": 0.85,
      "is_alias": false,
      "locus_type": "gene with protein product",
      "chromosome": null,
      "codes": {
        "hgnc_id": "1078",
        "entrez": "659",
        "ensembl": "ENSG00000204217",
        "uniprot": "Q13873",
        "omim": "600799"
      },
      "all_identifiers": [
        {
          "system": "HGNC",
          "code": "1078",
          "display": null
        },
        {
          "system": "ENTREZ",
          "code": "659",
          "display": null
        },
        {
          "system": "ENSEMBL",
          "code": "ENSG00000204217",
          "display": null
        },
        {
          "system": "OMIM",
          "code": "600799",
          "display": null
        },
        {
          "system": "UNIPROT",
          "code": "Q13873",
          "display": null
        }
      ],
      "associated_diseases": [
        {
          "orphacode": "275777",
          "disease_name": "Heritable pulmonary arterial hypertension",
          "association_type": "Disease-causing germline mutation(s) (loss of function) in"
        },
        {
          "orphacode": "275786",
          "disease_name": "Drug- or toxin-induced pulmonary arterial hypertension",
          "association_type": "Major susceptibility factor in"
        },
        {
          "orphacode": "31837",
          "disease_name": "Pulmonary venoocclusive disease",
          "association_type": "Candidate gene tested in"
        }
      ],
      "context": "tudy demonstrated that SOC channel inhibition may also partly reduce endothelial dysfunction.\n\nPAH (n=13) Control (n=12) Age, years 13 (46) 72 51 (66) 77 Sex, M/F 3 M/ M/8F Diseases Diagnosis 31% hPAH 100% lung 38% iPAH cancer 8% PVOD 159% PAH with congenital heart disease 8% PH group 5 Mutation in BMPR2 gene Carrier 3 NA no-carrier 10 NA Mutation in SOX17 gene Carrier 1 NA no-carrier 12 NA Hemodynamic parameters mPAP, mmHg 38 (52,5) 65 NA i, L/min/m? 2,1 (2,66) 3,13 NA PVR, Wood units 3,9 (11,22) 18 NA Medication Monotherapies NA NA Bitherapies NA NA\n\nConclusions\n\nUsing primary hPECs from control",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_08_orphadata_genes.json",
      "validation_flags": [
        "auto_validated_lexicon",
        "deduplicated"
      ]
    },
    {
      "matched_text": "SOX17",
      "hgnc_symbol": "SOX17",
      "full_name": "SRY-box transcription factor 17",
      "confidence": 0.85,
      "is_alias": false,
      "locus_type": "gene with protein product",
      "chromosome": null,
      "codes": {
        "hgnc_id": "18122",
        "entrez": "64321",
        "ensembl": "ENSG00000164736",
        "uniprot": "Q9H6I2",
        "omim": "610928"
      },
      "all_identifiers": [
        {
          "system": "HGNC",
          "code": "18122",
          "display": null
        },
        {
          "system": "ENTREZ",
          "code": "64321",
          "display": null
        },
        {
          "system": "ENSEMBL",
          "code": "ENSG00000164736",
          "display": null
        },
        {
          "system": "OMIM",
          "code": "610928",
          "display": null
        },
        {
          "system": "UNIPROT",
          "code": "Q9H6I2",
          "display": null
        }
      ],
      "associated_diseases": [
        {
          "orphacode": "275777",
          "disease_name": "Heritable pulmonary arterial hypertension",
          "association_type": "Major susceptibility factor in"
        },
        {
          "orphacode": "289365",
          "disease_name": "Familial vesicoureteral reflux",
          "association_type": "Disease-causing germline mutation(s) in"
        }
      ],
      "context": "o partly reduce endothelial dysfunction.\n\nPAH (n=13) Control (n=12) Age, years 13 (46) 72 51 (66) 77 Sex, M/F 3 M/ M/8F Diseases Diagnosis 31% hPAH 100% lung 38% iPAH cancer 8% PVOD 159% PAH with congenital heart disease 8% PH group 5 Mutation in BMPR2 gene Carrier 3 NA no-carrier 10 NA Mutation in SOX17 gene Carrier 1 NA no-carrier 12 NA Hemodynamic parameters mPAP, mmHg 38 (52,5) 65 NA i, L/min/m? 2,1 (2,66) 3,13 NA PVR, Wood units 3,9 (11,22) 18 NA Medication Monotherapies NA NA Bitherapies NA NA\n\nConclusions\n\nUsing primary hPECs from control and patients suffering from PAH, we found that hPECs",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_08_orphadata_genes.json",
      "validation_flags": [
        "auto_validated_lexicon",
        "deduplicated"
      ]
    },
    {
      "matched_text": "STIM1",
      "hgnc_symbol": "STIM1",
      "full_name": "stromal interaction molecule 1",
      "confidence": 0.85,
      "is_alias": false,
      "locus_type": "gene with protein product",
      "chromosome": null,
      "codes": {
        "hgnc_id": "11386",
        "entrez": "6786",
        "ensembl": "ENSG00000167323",
        "uniprot": "Q13586",
        "omim": "605921"
      },
      "all_identifiers": [
        {
          "system": "HGNC",
          "code": "11386",
          "display": null
        },
        {
          "system": "ENTREZ",
          "code": "6786",
          "display": null
        },
        {
          "system": "ENSEMBL",
          "code": "ENSG00000167323",
          "display": null
        },
        {
          "system": "OMIM",
          "code": "605921",
          "display": null
        },
        {
          "system": "UNIPROT",
          "code": "Q13586",
          "display": null
        }
      ],
      "associated_diseases": [
        {
          "orphacode": "3204",
          "disease_name": "Stormorken-Sjaastad-Langslet syndrome",
          "association_type": "Disease-causing germline mutation(s) (gain of function) in"
        },
        {
          "orphacode": "2593",
          "disease_name": "Tubular aggregate myopathy",
          "association_type": "Disease-causing germline mutation(s) (gain of function) in"
        },
        {
          "orphacode": "317430",
          "disease_name": "Combined immunodeficiency due to STIM1 deficiency",
          "association_type": "Disease-causing germline mutation(s) in"
        }
      ],
      "context": "PECs medium. Finally, we found that TRPC1 is crucial for endothelial cell homeostasis. Together, these results demonstrate that TRPC channels are central and represent very interesting candidates for reducing endothelial dysfunction in PAH.\n\nTritherapies\n\n46%\n\nNA\n\nMethods\n\nreports demonstrated that STIM1 could interact and activate TRPC1 and TRPC4 channels [43] directly, we supposed that in PAH-hPECs, TRPC1 and TRPC4 are involved in SOCE via STIM1 interaction during ER Ca”* depletion.\n\nCulture of hPECs and hPASMCs isolated from PAH and\n\ncontrol patients\n\nCells were isolated as previously described",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_08_orphadata_genes.json",
      "validation_flags": [
        "auto_validated_lexicon",
        "deduplicated"
      ]
    },
    {
      "matched_text": "EGF",
      "hgnc_symbol": "EGF",
      "full_name": "epidermal growth factor",
      "confidence": 0.85,
      "is_alias": false,
      "locus_type": "gene with protein product",
      "chromosome": null,
      "codes": {
        "hgnc_id": "3229",
        "entrez": "1950",
        "ensembl": "ENSG00000138798",
        "uniprot": "P01133",
        "omim": "131530"
      },
      "all_identifiers": [
        {
          "system": "HGNC",
          "code": "3229",
          "display": null
        },
        {
          "system": "ENTREZ",
          "code": "1950",
          "display": null
        },
        {
          "system": "ENSEMBL",
          "code": "ENSG00000138798",
          "display": null
        },
        {
          "system": "OMIM",
          "code": "131530",
          "display": null
        },
        {
          "system": "UNIPROT",
          "code": "P01133",
          "display": null
        }
      ],
      "associated_diseases": [
        {
          "orphacode": "210159",
          "disease_name": "Adult hepatocellular carcinoma",
          "association_type": "Major susceptibility factor in"
        },
        {
          "orphacode": "620368",
          "disease_name": "EGF-related primary hypomagnesemia with intellectual disability",
          "association_type": "Disease-causing germline mutation(s) in"
        }
      ],
      "context": "ATT, Thermo Fisher Scientific Antisense : UCACUAAACAUGUAUGCUGGT\n\nTable 2 List of SIRNA used in the experiments\n\nwere cultured in DMEM (Gibco, ref 11960044) supple-mented with 12,5% FCS, 2 mmol/L L-Glutamine, 1X Insulin-Transferin-Selenium, 100 U/mL penicillin-streptomycin, 20 mmol/L HEPES, 10 ng/mL EGF.\n\nClinical data of control and PAH patients used for the study are summarized in Table 1.\n\nSIRNA transfection\n\nhPECs were transfected in suspension by incubating 4x10° cells in a solution containing 1000 pL of OptiMEM (Gibco, ref 31985-062), 6 pL of Lipofectamine RNAiMax (Invitrogen, ref 13778-150)",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_08_orphadata_genes.json",
      "validation_flags": [
        "auto_validated_lexicon",
        "deduplicated"
      ]
    },
    {
      "matched_text": "kit",
      "hgnc_symbol": "KIT",
      "full_name": "KIT proto-oncogene, receptor tyrosine kinase",
      "confidence": 0.85,
      "is_alias": false,
      "locus_type": "gene with protein product",
      "chromosome": null,
      "codes": {
        "hgnc_id": "6342",
        "entrez": "3815",
        "ensembl": "ENSG00000157404",
        "uniprot": "P10721",
        "omim": "164920"
      },
      "all_identifiers": [
        {
          "system": "HGNC",
          "code": "6342",
          "display": null
        },
        {
          "system": "ENTREZ",
          "code": "3815",
          "display": null
        },
        {
          "system": "ENSEMBL",
          "code": "ENSG00000157404",
          "display": null
        },
        {
          "system": "OMIM",
          "code": "164920",
          "display": null
        },
        {
          "system": "UNIPROT",
          "code": "P10721",
          "display": null
        }
      ],
      "associated_diseases": [
        {
          "orphacode": "158769",
          "disease_name": "Plaque-form urticaria pigmentosa",
          "association_type": "Disease-causing germline mutation(s) in"
        },
        {
          "orphacode": "158766",
          "disease_name": "Typical urticaria pigmentosa",
          "association_type": "Disease-causing germline mutation(s) in"
        },
        {
          "orphacode": "158778",
          "disease_name": "Isolated bone marrow mastocytosis",
          "association_type": "Disease-causing somatic mutation(s) in"
        },
        {
          "orphacode": "158775",
          "disease_name": "Smoldering systemic mastocytosis",
          "association_type": "Disease-causing somatic mutation(s) in"
        },
        {
          "orphacode": "158772",
          "disease_name": "Nodular urticaria pigmentosa",
          "association_type": "Disease-causing germline mutation(s) in"
        },
        {
          "orphacode": "2884",
          "disease_name": "Piebaldism",
          "association_type": "Disease-causing germline mutation(s) (loss of function) in"
        },
        {
          "orphacode": "842",
          "disease_name": "Testicular seminomatous germ cell tumor",
          "association_type": "Disease-causing somatic mutation(s) in"
        },
        {
          "orphacode": "280785",
          "disease_name": "Bullous diffuse cutaneous mastocytosis",
          "association_type": "Disease-causing germline mutation(s) in"
        },
        {
          "orphacode": "280794",
          "disease_name": "Pseudoxanthomatous diffuse cutaneous mastocytosis",
          "association_type": "Disease-causing germline mutation(s) in"
        },
        {
          "orphacode": "566393",
          "disease_name": "Acute mast cell leukemia",
          "association_type": "Disease-causing germline mutation(s) in"
        },
        {
          "orphacode": "566396",
          "disease_name": "Chronic mast cell leukemia",
          "association_type": "Disease-causing germline mutation(s) in"
        },
        {
          "orphacode": "44890",
          "disease_name": "Gastrointestinal stromal tumor",
          "association_type": "Disease-causing somatic mutation(s) in"
        },
        {
          "orphacode": "90389",
          "disease_name": "Telangiectasia macularis eruptiva perstans",
          "association_type": "Disease-causing germline mutation(s) in"
        },
        {
          "orphacode": "79455",
          "disease_name": "Cutaneous mastocytoma",
          "association_type": "Disease-causing germline mutation(s) in"
        },
        {
          "orphacode": "98834",
          "disease_name": "Acute myeloblastic leukemia with maturation",
          "association_type": "Disease-causing somatic mutation(s) in"
        },
        {
          "orphacode": "98829",
          "disease_name": "Acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)",
          "association_type": "Biomarker tested in"
        },
        {
          "orphacode": "98849",
          "disease_name": "Systemic mastocytosis with associated hematologic neoplasm",
          "association_type": "Disease-causing somatic mutation(s) in"
        },
        {
          "orphacode": "102724",
          "disease_name": "Acute myeloid leukemia with t(8;21)(q22;q22) translocation",
          "association_type": "Biomarker tested in"
        }
      ],
      "context": "sfection.\n\nReverse transcription-quantitative PCR (RT-qPCR)\n\nTotal RNA from hPECs was isolated by using a TRIzol reagent. RNA concentration and purity were evaluated on a NanoDrop (Thermo Scientific, USA) spectropho-tometer measuring absorbance at 230, 260, and 280 nm. RT was performed with a StaRT kit from Anygenes (Paris, France) according to the manufacturer’s protocol, and qPCR was performed with perfect Master Mix SYBR Green (with ROX) for SignAray 96 system from Anygenes according to the manufacturer’s protocol on a Plus Real-Time PCR System (Life Technologies) and analyzed with StepOne Sof",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_08_orphadata_genes.json",
      "validation_flags": [
        "auto_validated_lexicon",
        "pubtator_enriched",
        "deduplicated"
      ]
    },
    {
      "matched_text": "Ca2",
      "hgnc_symbol": "CA2",
      "full_name": "carbonic anhydrase 2",
      "confidence": 0.85,
      "is_alias": false,
      "locus_type": "gene with protein product",
      "chromosome": null,
      "codes": {
        "hgnc_id": "1373",
        "entrez": "760",
        "ensembl": "ENSG00000104267",
        "uniprot": "P00918",
        "omim": "611492"
      },
      "all_identifiers": [
        {
          "system": "HGNC",
          "code": "1373",
          "display": null
        },
        {
          "system": "ENTREZ",
          "code": "760",
          "display": null
        },
        {
          "system": "ENSEMBL",
          "code": "ENSG00000104267",
          "display": null
        },
        {
          "system": "OMIM",
          "code": "611492",
          "display": null
        },
        {
          "system": "UNIPROT",
          "code": "P00918",
          "display": null
        }
      ],
      "associated_diseases": [
        {
          "orphacode": "2785",
          "disease_name": "Osteopetrosis with renal tubular acidosis",
          "association_type": "Disease-causing germline mutation(s) in"
        }
      ],
      "context": "ction plaques (PZ75A1H1-F) were used. All the primers used are summarized in Table 3.\n\nWestern blot analyses\n\nTotal proteins (20 yg) from hPECs or human lung-tissue samples were prepared as described previously [47]. Antibodies used for Western blot experiments are listed in Table 4.\n\nIntracellular Ca2* measurements\n\nhPECs were plated on 18-mm glass coverslips and loaded with 2 mol/L Fura-2-AM dissolved in DMSO plus 20% pluronic acid (Life Technologies) and then incubated at 37 °C for 30 min in darkness in Krebs solution (in mmol/L: 135 NaCl, 5.9 KCI, 2 CaCl,, 1 MgCl, 10 HEPES, 10 D-glucose) at p",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_08_orphadata_genes.json",
      "validation_flags": [
        "auto_validated_lexicon",
        "deduplicated"
      ]
    },
    {
      "matched_text": "Cat",
      "hgnc_symbol": "CAT",
      "full_name": "catalase",
      "confidence": 0.85,
      "is_alias": false,
      "locus_type": "gene with protein product",
      "chromosome": null,
      "codes": {
        "hgnc_id": "1516",
        "entrez": "847",
        "ensembl": "ENSG00000121691",
        "uniprot": "P04040",
        "omim": "115500"
      },
      "all_identifiers": [
        {
          "system": "HGNC",
          "code": "1516",
          "display": null
        },
        {
          "system": "ENTREZ",
          "code": "847",
          "display": null
        },
        {
          "system": "ENSEMBL",
          "code": "ENSG00000121691",
          "display": null
        },
        {
          "system": "OMIM",
          "code": "115500",
          "display": null
        },
        {
          "system": "UNIPROT",
          "code": "P04040",
          "display": null
        }
      ],
      "associated_diseases": [
        {
          "orphacode": "926",
          "disease_name": "Acatalasemia",
          "association_type": "Disease-causing germline mutation(s) in"
        }
      ],
      "context": "se Alexa 647 (to detect vWF) with 3% human serum and\n\nWound healing assay\n\nWe used the wound healing assay to evaluate cell migration. After 48 h of starvation (medium without growth factors: fetal calf serum (FCS), epidermal growth factor (EGF), and insulin), hPECs were plated in a culture insert (Cat. No. 90209; Ibidi) at a density of 2 x 10‘cells per well in a fresh medium with cytosine arabinoside (10 mol/L) to prevent cell proliferation. After allowing cells to attach for 24 h, we removed the culture insert and washed the cells with phosphate-buffered saline to remove non-adherent cells. Cel",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_08_orphadata_genes.json",
      "validation_flags": [
        "auto_validated_lexicon",
        "deduplicated"
      ]
    },
    {
      "matched_text": "Akt1",
      "hgnc_symbol": "AKT1",
      "full_name": "AKT serine/threonine kinase 1",
      "confidence": 0.85,
      "is_alias": false,
      "locus_type": "gene with protein product",
      "chromosome": null,
      "codes": {
        "hgnc_id": "391",
        "entrez": "207",
        "ensembl": "ENSG00000142208",
        "uniprot": "P31749",
        "omim": "164730"
      },
      "all_identifiers": [
        {
          "system": "HGNC",
          "code": "391",
          "display": null
        },
        {
          "system": "ENTREZ",
          "code": "207",
          "display": null
        },
        {
          "system": "ENSEMBL",
          "code": "ENSG00000142208",
          "display": null
        },
        {
          "system": "OMIM",
          "code": "164730",
          "display": null
        },
        {
          "system": "UNIPROT",
          "code": "P31749",
          "display": null
        }
      ],
      "associated_diseases": [
        {
          "orphacode": "201",
          "disease_name": "Cowden syndrome",
          "association_type": "Disease-causing germline mutation(s) (gain of function) in"
        },
        {
          "orphacode": "744",
          "disease_name": "Proteus syndrome",
          "association_type": "Disease-causing somatic mutation(s) in"
        },
        {
          "orphacode": "2495",
          "disease_name": "Meningioma",
          "association_type": "Disease-causing germline mutation(s) in"
        }
      ],
      "context": "lay a role in TRPC regulation under hypoxia? Pflugers Arch. 2016;468:23-41. https://doi.org/10.1007/s00424-015-1731-3.\n\nSankhe S, Manousakidi S, Antigny F, Arthur Ataam J, Bentebbal S, Ruchon Y, et al. T-type Ca2 + channels elicit pro-proliferative and anti-apoptotic responses through impaired PP2A/Akt1 signaling in PASMCs from patients with pulmonary arterial hypertension. Biochim Biophys Acta. 2017;1864:1631-41. https//doi.org/10.1016/j.bbamcr.2017.06.018.\n\n29, Veit F, Pak O, Brandes RP, Weissmann N. Hypoxia-dependent reactive oxygen species signaling in the pulmonary circulation: focus on ion c",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_08_orphadata_genes.json",
      "validation_flags": [
        "auto_validated_lexicon",
        "deduplicated"
      ]
    },
    {
      "matched_text": "Kcnk3",
      "hgnc_symbol": "KCNK3",
      "full_name": "potassium two pore domain channel subfamily K member 3",
      "confidence": 0.85,
      "is_alias": false,
      "locus_type": "gene with protein product",
      "chromosome": null,
      "codes": {
        "hgnc_id": "6278",
        "entrez": "3777",
        "ensembl": "ENSG00000171303",
        "uniprot": "O14649",
        "omim": "603220"
      },
      "all_identifiers": [
        {
          "system": "HGNC",
          "code": "6278",
          "display": null
        },
        {
          "system": "ENTREZ",
          "code": "3777",
          "display": null
        },
        {
          "system": "ENSEMBL",
          "code": "ENSG00000171303",
          "display": null
        },
        {
          "system": "OMIM",
          "code": "603220",
          "display": null
        },
        {
          "system": "UNIPROT",
          "code": "O14649",
          "display": null
        }
      ],
      "associated_diseases": [
        {
          "orphacode": "275777",
          "disease_name": "Heritable pulmonary arterial hypertension",
          "association_type": "Disease-causing germline mutation(s) (loss of function) in"
        }
      ],
      "context": "s://doi.org/10.1089/ars.2014.6234.\n\n30, Kozai D, Ogawa N, Mori Y. Redox regulation of transient receptor potential channels. Antioxid Redox Signal. 2014;21:971-86. https://doi.org/10.1089/ars. 2013.5616.\n\n45, Lambert M, Capuano V, Boet A, Tesson L, Bertero T, Nakhleh MK, et al. Charac-terization of Kcnk3 -mutated rat, a novel model of pulmonary hypertension. Circ Res. 2019;125:678-95. https://doi.org/10.1161/CIRCRESAHA.119.314793\n\n31 Quinlan CL, Perevoshchikova IV, Hey-Mogensen M, Orr AL, Brand MD. Sites of reactive oxygen species generation by mitochondria oxidizing different substrates. Redox Bio",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_08_orphadata_genes.json",
      "validation_flags": [
        "auto_validated_lexicon",
        "pubtator_enriched",
        "deduplicated"
      ]
    },
    {
      "matched_text": "Orai1",
      "hgnc_symbol": "ORAI1",
      "full_name": "ORAI calcium release-activated calcium modulator 1",
      "confidence": 0.85,
      "is_alias": false,
      "locus_type": "gene with protein product",
      "chromosome": null,
      "codes": {
        "hgnc_id": "25896",
        "entrez": "84876",
        "ensembl": "ENSG00000276045",
        "uniprot": "Q96D31",
        "omim": "610277"
      },
      "all_identifiers": [
        {
          "system": "HGNC",
          "code": "25896",
          "display": null
        },
        {
          "system": "ENTREZ",
          "code": "84876",
          "display": null
        },
        {
          "system": "ENSEMBL",
          "code": "ENSG00000276045",
          "display": null
        },
        {
          "system": "OMIM",
          "code": "610277",
          "display": null
        },
        {
          "system": "UNIPROT",
          "code": "Q96D31",
          "display": null
        }
      ],
      "associated_diseases": [
        {
          "orphacode": "3204",
          "disease_name": "Stormorken-Sjaastad-Langslet syndrome",
          "association_type": "Disease-causing germline mutation(s) (gain of function) in"
        },
        {
          "orphacode": "2593",
          "disease_name": "Tubular aggregate myopathy",
          "association_type": "Disease-causing germline mutation(s) (gain of function) in"
        },
        {
          "orphacode": "317428",
          "disease_name": "Combined immunodeficiency due to ORAI1 deficiency",
          "association_type": "Disease-causing germline mutation(s) in"
        }
      ],
      "context": "/doi.org/10.1038/nrm3412.\n\n47. Le Ribeuz H, Masson B, Capuano V, Dutheil M, Gooroochurn H, Boét A, et al SUR1 as a new therapeutic target for pulmonary arterial hypertension. Am J Respir Cell Mol Biol. 2022. https://doi.org/10.1165/rcmb.2021-01800C.\n\n33 Willer AS-M, Montani D, Capuano V, Antigny F. Orai1/STIMs modulators in pulmonary vascular diseases. Cell Calcium. 2024;102892. https://doi.org/10.1 016/j.ceca.2024.102892.\n\n48. Carpentier G, Berndt S, Ferratge S, Rasband W, Cuendet M, Uzan G, et al. Angiogenesis analyzer for ImageJ - a comparative morphometric analysis of endothelial tube formation",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_08_orphadata_genes.json",
      "validation_flags": [
        "auto_validated_lexicon",
        "deduplicated"
      ]
    },
    {
      "matched_text": "Fig",
      "hgnc_symbol": "GOPC",
      "full_name": "golgi associated PDZ and coiled-coil motif containing",
      "confidence": 0.8,
      "is_alias": true,
      "locus_type": "gene with protein product",
      "chromosome": null,
      "codes": {
        "hgnc_id": "17643",
        "entrez": "57120",
        "ensembl": "ENSG00000047932",
        "uniprot": "Q9HD26",
        "omim": "606845"
      },
      "all_identifiers": [
        {
          "system": "HGNC",
          "code": "17643",
          "display": null
        },
        {
          "system": "ENTREZ",
          "code": "57120",
          "display": null
        },
        {
          "system": "ENSEMBL",
          "code": "ENSG00000047932",
          "display": null
        },
        {
          "system": "OMIM",
          "code": "606845",
          "display": null
        },
        {
          "system": "UNIPROT",
          "code": "Q9HD26",
          "display": null
        }
      ],
      "associated_diseases": [],
      "context": "rsity, Créteil, France 3Inserm, UMR_S 1180, Signalisation et Physiopathologie Cardiovasculaire, Université Paris-Saclay, Orsay, France\n\nIntroduction\n\nare expressed in the PA, and more particularly in hPECs in control and PAH patients as indicated by the co-staining with von Willebrand factor (vWF) (Fig. 1A). To decipher the role of each expressed TRPC channel, we performed in vitro experiments using control-hPECs.\n\nEndothelial cell dysfunction is a key contributor to the pathogenesis of pulmonary arterial (PA) hypertension (PAH), a rare and life-threatening pulmonary vascular disease defined by a",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_08_orphadata_genes.json",
      "validation_flags": [
        "auto_validated_lexicon",
        "deduplicated"
      ]
    },
    {
      "matched_text": "1D",
      "hgnc_symbol": "LMOD1",
      "full_name": "leiomodin 1",
      "confidence": 0.8,
      "is_alias": true,
      "locus_type": "gene with protein product",
      "chromosome": null,
      "codes": {
        "hgnc_id": "6647",
        "entrez": "25802",
        "ensembl": "ENSG00000163431",
        "uniprot": "P29536",
        "omim": "602715"
      },
      "all_identifiers": [
        {
          "system": "HGNC",
          "code": "6647",
          "display": null
        },
        {
          "system": "ENTREZ",
          "code": "25802",
          "display": null
        },
        {
          "system": "ENSEMBL",
          "code": "ENSG00000163431",
          "display": null
        },
        {
          "system": "OMIM",
          "code": "602715",
          "display": null
        },
        {
          "system": "UNIPROT",
          "code": "P29536",
          "display": null
        }
      ],
      "associated_diseases": [],
      "context": "racellular Ca”*. To elicit the contribution of each channel, we used a small interfering RNA (siRNA) strategy. The efficacy of each siRNA was previously validated [13]. 72 h after cell transfection, we found that the knockdown of TRPC1, TRPC3, TRPC4, and TRPC6 had no impact on ER Ca** release (Fig. 1D). The knockdown of TRPC4 decreased SOCE, whereas the knockdown of TRPC1, TRPC3, and TRPC6 had no impact on SOCE (Fig. 1E) in control-hPECs.\n\nWe performed experiments to measure the contribution of each SOC channel to Ca’* signaling induced by the activation of the G protein-coupled receptor with 1",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_08_orphadata_genes.json",
      "validation_flags": [
        "auto_validated_lexicon",
        "deduplicated"
      ]
    },
    {
      "matched_text": "II",
      "hgnc_symbol": "GCNT2",
      "full_name": "glucosaminyl (N-acetyl) transferase 2 (I blood group)",
      "confidence": 0.8,
      "is_alias": true,
      "locus_type": "gene with protein product",
      "chromosome": null,
      "codes": {
        "hgnc_id": "4204",
        "entrez": "2651",
        "ensembl": "ENSG00000111846",
        "uniprot": "Q8N0V5",
        "omim": "600429"
      },
      "all_identifiers": [
        {
          "system": "HGNC",
          "code": "4204",
          "display": null
        },
        {
          "system": "ENTREZ",
          "code": "2651",
          "display": null
        },
        {
          "system": "ENSEMBL",
          "code": "ENSG00000111846",
          "display": null
        },
        {
          "system": "OMIM",
          "code": "600429",
          "display": null
        },
        {
          "system": "UNIPROT",
          "code": "Q8N0V5",
          "display": null
        }
      ],
      "associated_diseases": [],
      "context": "Fig. 3C) were unchanged in PAH-hPECs compared to control-hPECs, while histamine-induced Ca’* signaling was reduced in PAH-hPECs compared to control-hPECs (Fig. 3D-E).\n\nPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-Alpha (PPARGC1A), Endothelin receptor type A (EDNRA) and Angiotensin II Receptor Type 1 (AGTR1) (Fig. 6A). Moreover, no significant change was observed in the expression of the other 80 endothelial markers (Table 3). These results suggest that TRPC1 partly contributes to endothelial dysfunction in PAH disease. We also found that TRPC3 knockdown increased mRNA expressio",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_08_orphadata_genes.json",
      "validation_flags": [
        "auto_validated_lexicon",
        "deduplicated"
      ]
    },
    {
      "matched_text": "ROS",
      "hgnc_symbol": "ROS1",
      "full_name": "ROS proto-oncogene 1, receptor tyrosine kinase",
      "confidence": 0.8,
      "is_alias": true,
      "locus_type": "gene with protein product",
      "chromosome": null,
      "codes": {
        "hgnc_id": "10261",
        "entrez": "6098",
        "ensembl": "ENSG00000047936",
        "uniprot": "P08922",
        "omim": "165020"
      },
      "all_identifiers": [
        {
          "system": "HGNC",
          "code": "10261",
          "display": null
        },
        {
          "system": "ENTREZ",
          "code": "6098",
          "display": null
        },
        {
          "system": "ENSEMBL",
          "code": "ENSG00000047936",
          "display": null
        },
        {
          "system": "OMIM",
          "code": "165020",
          "display": null
        },
        {
          "system": "UNIPROT",
          "code": "P08922",
          "display": null
        }
      ],
      "associated_diseases": [],
      "context": "ns\n\na\n\nSp &\n\nATP can buffer Ca”*, relieving the inhibitory effect of incoming Ca”* on SOCE activity [27]. We can therefore conclude that the metabolic status of mitochondria is key to regulating intracellular ATP content, which in turn affects SOCE activity. Mitochondrial status can also influence ROS production, which can modulate TRPC channel function [28-30]. ROS are mainly handled by the mitochondria and are linked to SOCE activity [31, 32]. In addition, SOCE is a complex mechanism involving several modulating proteins, and each of them could modulate SOCE negatively and positively [33]. To",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_08_orphadata_genes.json",
      "validation_flags": [
        "auto_validated_lexicon",
        "deduplicated"
      ]
    },
    {
      "matched_text": "TRP",
      "hgnc_symbol": "TYRP1",
      "full_name": "tyrosinase related protein 1",
      "confidence": 0.8,
      "is_alias": true,
      "locus_type": "gene with protein product",
      "chromosome": null,
      "codes": {
        "hgnc_id": "12450",
        "entrez": "7306",
        "ensembl": "ENSG00000107165",
        "uniprot": "P17643",
        "omim": "115501"
      },
      "all_identifiers": [
        {
          "system": "HGNC",
          "code": "12450",
          "display": null
        },
        {
          "system": "ENTREZ",
          "code": "7306",
          "display": null
        },
        {
          "system": "ENSEMBL",
          "code": "ENSG00000107165",
          "display": null
        },
        {
          "system": "OMIM",
          "code": "115501",
          "display": null
        },
        {
          "system": "UNIPROT",
          "code": "P17643",
          "display": null
        }
      ],
      "associated_diseases": [],
      "context": "s a complex mechanism involving several modulating proteins, and each of them could modulate SOCE negatively and positively [33]. To our knowledge, the level of expression of these different SOCE modulating proteins is unknown in PAH-hPECs. Finally, the lipid membrane composition can also influence TRP channel function [34]. To better understand all these aspects of TRPC regulation in PAH and control-hPECs, several key experiments are necessary in further studies.\n\nFig. 4 Consequences of TRPC channels knockdown in PAH-hPECs. A Illustrations of the 340/380 ratio in SOCE protocol mediated by Thapsi",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_08_orphadata_genes.json",
      "validation_flags": [
        "auto_validated_lexicon",
        "deduplicated"
      ]
    },
    {
      "matched_text": "Slug",
      "hgnc_symbol": "SNAI2",
      "full_name": "snail family transcriptional repressor 2",
      "confidence": 0.8,
      "is_alias": true,
      "locus_type": "gene with protein product",
      "chromosome": null,
      "codes": {
        "hgnc_id": "11094",
        "entrez": "6591",
        "ensembl": "ENSG00000019549",
        "uniprot": "O43623",
        "omim": "602150"
      },
      "all_identifiers": [
        {
          "system": "HGNC",
          "code": "11094",
          "display": null
        },
        {
          "system": "ENTREZ",
          "code": "6591",
          "display": null
        },
        {
          "system": "ENSEMBL",
          "code": "ENSG00000019549",
          "display": null
        },
        {
          "system": "OMIM",
          "code": "602150",
          "display": null
        },
        {
          "system": "UNIPROT",
          "code": "O43623",
          "display": null
        }
      ],
      "associated_diseases": [],
      "context": "4;129:1586-97. https://doi.org/10.1161/CIRCUL ATIONAHA.113.007469.\n\nThe authors declare no competing interests.\n\nHopper RK, Moonen J-RAJ, Diebold I, Cao A, Rhodes CJ, Tojais NF. In pulmonary arterial hypertension, reduced BMPR2 promotes endothelial-to-mesenchymal transition via HMGA1 and its target Slug. Circulation. 2016;133:1783-94, https://doi.org/10.1161/CIRCULATIONAHA.1 15.020617.\n\nReferences\n\nSturtzel C. Endothelial cells. Adv Exp Med Biol. 2017;1003:71-91. https://doi.or 9/10.1007/978-3-319-57613-8_4.\n\n1. Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, et al. 2022 ESC/ER",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_08_orphadata_genes.json",
      "validation_flags": [
        "auto_validated_lexicon",
        "pubtator_enriched",
        "deduplicated"
      ]
    },
    {
      "matched_text": "SUR1",
      "hgnc_symbol": "ABCC8",
      "full_name": "ATP binding cassette subfamily C member 8",
      "confidence": 0.8,
      "is_alias": true,
      "locus_type": "gene with protein product",
      "chromosome": null,
      "codes": {
        "hgnc_id": "59",
        "entrez": "6833",
        "ensembl": "ENSG00000006071",
        "uniprot": "Q09428",
        "omim": "600509"
      },
      "all_identifiers": [
        {
          "system": "HGNC",
          "code": "59",
          "display": null
        },
        {
          "system": "ENTREZ",
          "code": "6833",
          "display": null
        },
        {
          "system": "ENSEMBL",
          "code": "ENSG00000006071",
          "display": null
        },
        {
          "system": "OMIM",
          "code": "600509",
          "display": null
        },
        {
          "system": "UNIPROT",
          "code": "Q09428",
          "display": null
        }
      ],
      "associated_diseases": [],
      "context": ".org/10.1165/rcmb.2023-01850C.\n\n32, Rizzuto R, De Stefani D, Raffaello A, Mammucari C. Mitochondria as sensors and regulators of calcium signalling. Nat Rev Mol Cell Biol. 2012;13:566-78. https://doi.org/10.1038/nrm3412.\n\n47. Le Ribeuz H, Masson B, Capuano V, Dutheil M, Gooroochurn H, Boét A, et al SUR1 as a new therapeutic target for pulmonary arterial hypertension. Am J Respir Cell Mol Biol. 2022. https://doi.org/10.1165/rcmb.2021-01800C.\n\n33 Willer AS-M, Montani D, Capuano V, Antigny F. Orai1/STIMs modulators in pulmonary vascular diseases. Cell Calcium. 2024;102892. https://doi.org/10.1 016/j.",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_08_orphadata_genes.json",
      "validation_flags": [
        "auto_validated_lexicon",
        "pubtator_enriched",
        "deduplicated"
      ]
    }
  ]
}